Krystal Biotech, Inc.

KRYS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$344,865$358,328$161,900$341,246
Short-Term Investments$252,652$173,850$217,271$96,850
Receivables$104,746$42,040$0$0
Inventory$26,508$6,985$0$0
Other Curr. Assets$13,274$6,706$4,608$4,171
Total Curr. Assets$742,045$587,909$383,779$442,267
Property Plant & Equip (Net)$161,448$168,229$169,726$119,583
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$152,114$61,954$4,621$64,371
Tax Assets$0$0$0$0
Other NC Assets$231$263$324$74
Total NC Assets$313,793$230,446$174,671$184,028
Other Assets$0$0$0$0
Total Assets$1,055,838$818,355$558,450$626,295
Liabilities
Payables$4,985$1,849$3,981$8,398
Short-Term Debt$1,217$1,474$1,561$1,041
Tax Payable$4,288$2,283$43$83
Deferred Revenue$0$0$0$0
Other Curr. Liab.$91,505$27,488$23,262$16,214
Total Curr. Liab.$101,995$33,094$28,847$25,736
LT Debt$6,044$6,620$7,372$6,983
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,419$0$0$0
Total NC Liab.$7,463$6,620$7,372$6,983
Other Liabilities$0$0$0$0
Cap. Leases$7,261$8,094$8,933$8,024
Total Liabilities$109,458$39,714$36,219$32,719
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$180,668-$269,827-$280,759-$140,784
AOCI-$190$638-$728-$163
Other Equity$1,127,238$1,047,830$803,718$734,523
Total Equity$946,380$778,641$522,231$593,576
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,055,838$818,355$558,450$626,295
Net Debt-$337,604-$350,234-$152,967-$333,222